Treatment with Aβ42 binding d-amino acid peptides reduce amyloid deposition and inflammation in APP/PS1 double transgenic mice

Advances in Protein Chemistry and Structural Biology

Volumn 88, Issue , 2012, Pages 133-152

  Van Groen, Thomas ^a,b   Kadish, Inga ^a   Funke, Aileen ^c   Bartnik, Dirk ^c   Willbold, Dieter ^c,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Amyloid; Limbic system; Mouse; Plaques; Treatment

Indexed keywords

EID: 84863960017     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398314-5.00005-2     Document Type: Chapter

References (52)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, and G.M. Cole Inflammation and Alzheimer's disease Neurobiology of Aging 21 3 2000 383 421 (Pubitemid 30349107)
2. D. Bartnik, S.A. Funke, L.C. Andrei-Selmer, M. Bacher, R. Dodel, and D. Willbold Differently selected D-enantiomeric peptides act on different Abeta species Rejuvenation Research 13 2010 202 205
3. M. Bartolini, C. Bertucci, M.L. Bolognesi, A. Cavalli, C. Melchiorre, and V. Andrisano Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: Elucidation of inhibitors' mechanism of action Chembiochem 8 2007 2152 2161 (Pubitemid 350220767)
4. L. Bondolfi, M. Calhoun, F. Ermini, H.G. Kuhn, K.H. Wiederhold, and L. Walker Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice Journal of Neuroscience 22 2002 515 522 (Pubitemid 34049090)
5. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 82 1991 239 259
6. H. Braak, and E. Braak Evolution of neuronal changes in the course of Alzheimer's disease Journal of Neural Transmission 53 1998 127 140 (Pubitemid 28361774)
7. J.D. Buxbaum, G. Thinakaran, V. Koliatsos, J. O'Callahan, H.H. Slunt, and D.L. Price Alzheimer amyloid precursor protein in the rat hippocampus: Transport and processing through the perforant path Journal of Neuroscience 18 1998 9629 9637 (Pubitemid 28543744)
8. T.C. Dickson, and J.C. Vickers The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease Neuroscience 105 2001 99 107 (Pubitemid 32722097)
9. G. Drin, S. Cottin, E. Blanc, A.R. Rees, and J. Temsamani Studies on the internalization mechanism of cationic cell-penetrating peptides Journal of Biological Chemistry 278 2003 31192 31201 (Pubitemid 36994635)
10. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press New York
11. S.A. Funke, T. van Groen, I. Kadish, D. Bartnik, L. Nagel-Steger, and O. Brener Oral treatment with the D-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's disease transgenic mice ACS Chemical Neuroscience 1 2010 639 648
12. D.C. German, and A.J. Eisch Mouse models of Alzheimer's disease: Insight into treatment Reviews in the Neurosciences 15 2004 353 369 (Pubitemid 39536384)
13. C. Haass, and B. De Strooper The presenilins in Alzheimer's disease - Proteolysis holds the key Science 286 1999 916 919
14. J. Hardy An 'anatomical cascade hypothesis' for Alzheimer's disease Trends in Neurosciences 15 6 1992 200 201
15. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: Prevalence estimates using the 2000 census Archives of Neurology 60 2003 1119 1122 (Pubitemid 36975801)
16. D. Hirtz, D.J. Thurman, K. Gwinn-Hardy, M. Mohamed, A.R. Chaudhuri, and R. Zalutsky How common are the "common" neurologic disorders? Neurology 68 2007 326 337 (Pubitemid 46188246)
17. B.T. Hyman, and J.Q. Trojanowski Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease Journal of Neuropathology and Experimental Neurology 56 1997 1095 1097
18. N. Ida, T. Hartmann, J. Pantel, J. Schröder, R. Zerfass, and H. Förstl Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay Journal of Biological Chemistry 271 1996 22908 22914 (Pubitemid 26304742)
19. K. Iijima, H.P. Liu, A.S. Chiang, S.A. Hearn, M. Konsolaki, and Y. Zhong Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: A potential model for Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 101 2004 6623 6628 (Pubitemid 38586024)
20. J.L. Jankowsky, H.H. Slunt, T. Ratovitski, N.A. Jenkins, N.G. Copeland, and D.R. Borchelt Co-expression of multiple transgenes in mouse CNS: A comparison of strategies Biomolecular Engineering 17 2001 157 165 (Pubitemid 32409891)
21. Y. Ji, B. Permanne, E.M. Sigurdsson, D.M. Holtzman, and T. Wisniewski Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice Journal of Alzheimer's Disease 3 2001 23 30 (Pubitemid 32238247)
22. I. Kadish, and T. van Groen Low levels of estrogen significantly diminish axonal sprouting after entorhinal cortex lesions in the mouse Journal of Neuroscience 22 10 2002 May 15 4095 4102 (Pubitemid 37465717)
23. S. Kumar-Singh Cerebral amyloid angiopathy: Pathogenetic mechanisms and link to dense amyloid plaques Genes, Brain, and Behavior 7 Suppl. 1 2008 67 82
24. V.M. Lee, M. Goedert, and J.Q. Trojanowski Neurodegenerative tauopathies Annual Review of Neuroscience 24 2001 1121 1159 (Pubitemid 32695256)
25. H. Liu, S.A. Funke, and D. Willbold Transport of Alzheimer disease amyloid-beta-binding d-amino acid peptides across an in vitro blood-brain barrier model Rejuvenation Research 13 2010 210 213
26. L. Liu, S. Ikonen, T. Heikkinen, M. Heikkilä, J. Puoliväli, and T. van Groen Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 mice Behavioural Brain Research 134 2002 433 445 (Pubitemid 34912723)
27. T.M. Malm, H. Iivonen, G. Goldsteins, V. Keksa-Goldsteine, T. Ahtoniemi, and K. Kanninen Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden Journal of Neuroscience 27 2007 3712 3721 (Pubitemid 46557689)
28. C.L. Masters, and K. Beyreuther Alzheimer's centennial legacy: Prospects for rational therapeutic intervention targeting the Aβ amyloid pathway Brain 29 2006 2823 2839 (Pubitemid 44684506)
29. S. Monaco, G. Zanusso, S. Mazzucco, and N. Rizzuto Cerebral amyloidoses: Molecular pathways and therapeutic challenges Current Medicinal Chemistry 13 2006 1903 1913
30. B. Permanne, C. Adessi, S. Fraga, M.J. Frossard, G.P. Saborio, and C. Soto Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease? Journal of Neural Transmission. Supplementum 62 2002 293 301 (Pubitemid 37046673)
31. B. Permanne, C. Adessi, G.P. Saborio, S. Fraga, M.J. Frossard, and J. Van Dorpe Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide The FASEB Journal 16 2002 860 862
32. R. Pluta, A. Misicka, M. Barcikowska, S. Spisacka, A.W. Lipkowski, and S. Januszewski Possible reverse transport of beta-amyloid peptide across the blood-brain barrier Acta Neurochirurgica. Supplement 76 2000 73 77
33. J. Rogers, and L.F. Lue Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease Neurochemistry International 39 2001 333 340 (Pubitemid 32907397)
34. D.J. Selkoe Alzheimer's disease: Genes, proteins, and therapy Physiological Reviews 81 2001 741 766 (Pubitemid 32267077)
35. D.J. Selkoe, and M.S. Wolfe Presenilin: Running with scissors in the membrane Cell 131 2007 215 221 (Pubitemid 47576152)
36. J.G. Sheng, D.L. Price, and V.E. Koliatsos Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis Journal of Neuroscience 22 2002 9794 9799 (Pubitemid 35332863)
37. C. Soto, M.S. Kindy, M. Baumann, and B. Frangione Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation Biochemical and Biophysical Research Communications 226 1996 672 680 (Pubitemid 26348532)
38. M. Stalder, T. Deller, M. Staufenbiel, and M. Jucker 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: No evidence of intracellular amyloid Neurobiology of Aging 22 2001 427 434 (Pubitemid 32510915)
39. R.E. Tanzi, and L. Bertram Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective Cell 120 4 2005 545 555 (Pubitemid 40269768)
40. R.E. Tanzi, R.D. Moir, and S.L. Wagner Clearance of Alzheimer's Abeta peptide: The many roads to perdition Neuron 43 2004 605 608 (Pubitemid 39179722)
41. B. Van Broeck, C. Van Broeckhoven, and S. Kumar-Singh Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches Neurodegenerative Diseases 4 2007 349 365 (Pubitemid 47123462)
42. T. van Groen, and I. Kadish Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology Brain Research Reviews 48 2005 370 378 (Pubitemid 40585768)
43. T. van Groen, I. Kadish, K. Wiesehan, S.A. Funke, and D. Willbold In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models ChemMedChem 4 2009 276 282
44. T. van Groen, A.J. Kiliaan, and I. Kadish Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice Neurobiology of Disease 23 2006 653 662 (Pubitemid 44234102)
45. T. van Groen, L. Liu, S. Ikonen, and I. Kadish Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions Neuroscience 119 2003 1185 1197 (Pubitemid 36776463)
46. T. van Groen, P. Miettinen, and I. Kadish Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology Journal of Alzheimer's Disease 24 2011 301 313
47. J. Wang, H. Tanila, J. Puolivali, I. Kadish, and T. van Groen Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice Neurobiology of Disease 14 2003 318 327 (Pubitemid 37543511)
48. Y.J. Wang, H.D. Zhou, and X.F. Zhou Clearance of amyloid-beta in Alzheimer's disease: Progress, problems and perspectives Drug Discovery Today 11 2006 931 938
49. K. Wiesehan, K. Buder, R.P. Linke, S. Patt, M. Stoldt, and E. Unger Selection of d-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display Chembiochem 4 2003 748 753 (Pubitemid 37010600)
50. K. Wiesehan, J. Stöhr, L. Nagel-Steger, T. van Groen, D. Riesner, and D. Willbold Inhibition of cytotoxicity and amyloid fibril formation by a d-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide Protein Engineering, Design & Selection 21 2008 241 246 (Pubitemid 351431052)
51. K. Wiesehan, and D. Willbold Mirror-image phage display: Aiming at the mirror Chembiochem 4 2003 811 815 (Pubitemid 37185690)
52. Y. Yoshiike, D.H. Chui, T. Akagi, N. Tanakama, and A. Takashima Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation Journal of Biological Chemistry 278 2003 23648 23655 (Pubitemid 36830187)